High-Risk Cytokine Profiles Predict Lower Survivals in AML after Allotransplantation

被引：0
|
作者：
Peterlin, Pierre [1 ,2 ]
Gaschet, Joelle [2 ]
Jullien, Maxime [3 ]
Guillaume, Thierry [4 ]
Garnier, Alice [3 ]
Le Bourgeois, Amandine [4 ]
Cherel, Michel [2 ]
Bene, Marie C. [5 ]
Chevallier, Patrice [3 ]
机构：
[1] Nantes Univ Hosp, Nantes, France
[2] Nantes Univ, Univ Angers, Univ Nantes, CNRS,Inserm UMR 1307,UMR 6075,CRCI,INSERM, Nantes, France
[3] Nantes Univ Hosp, Clin Hematol, Nantes, France
[4] Nantes Univ Hosp, Hematol Dept, Nantes, France
[5] Nantes Univ Hosp, Hematol Biol, Nantes, France
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165348
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12906 / 12907
页数：2
相关论文
共 50 条
  • [1] HIGH-RISK CYTOKINE PROFILES PREDICT LOWER SURVIVALS IN AML AFTER ALLOTRANSPLANTATION
    Peterlin, Pierre
    Gaschet, Joelle
    Jullien, Maxime
    Guillaume, Thierry
    Garnier, Alice
    Le Bourgeois, Amandine
    Cherel, Michel
    Bene, Marie-Christine
    Chevallier, Patrice
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 359 - 360
  • [2] Copy number profiles of high-risk MDS and AML patients
    Ganster, C.
    Braulke, F.
    Shirneshan, K.
    Schanz, J.
    Neesen, J.
    Salinas-Riester, G.
    Platzbecker, U.
    Haase, D.
    ONKOLOGIE, 2013, 36 : 239 - 240
  • [3] Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis
    Bhattacharyya, S
    Singla, R
    Dey, AB
    Prasad, HK
    INFECTION AND IMMUNITY, 1999, 67 (11) : 5597 - 5603
  • [4] HIGH-RISK AML: INDICATIONS FOR SCT?
    Hasle, H.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 709 - 709
  • [5] Novel Strategies in High-Risk AML
    Welch, John S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S82 - S85
  • [6] INDUCTION THERAPY FOR HIGH-RISK AML
    Schiffer, Charles A.
    LEUKEMIA RESEARCH, 2017, 61 : S2 - S2
  • [7] Prognostic significance of cytokine levels in newly-diagnosed AML and high-risk myelodysplasia.
    Albitar, M
    Estey, E
    Doherty, D
    Shen, Y
    Cortes, J
    O'Brien, S
    Giles, F
    Kantarjian, H
    Kurzrock, R
    BLOOD, 2001, 98 (11) : 327A - 327A
  • [8] Cytokine and chemokine profiles in episodes of persistent high-risk febrile neutropenia in children with cancer
    Tapia, Lorena, I
    Olivares, Mauricio
    Torres, Juan P.
    De la Maza, Veronica
    Valenzuela, Romina
    Contardo, Veronica
    Tordecilla, Juan
    Alvarez, Ana M.
    Varas, Monica
    Zubieta, Marcela
    Salgado, Carmen
    Venegas, Marcela
    Gutierrez, Valentina
    Claverie, Ximena
    Villarroel, Milena
    Santolaya, Maria E.
    CYTOKINE, 2021, 148
  • [9] Quizartinib tested in patients with high-risk AML
    Sidaway P.
    Nature Reviews Clinical Oncology, 2018, 15 (9) : 532 - 532
  • [10] Rapid Evaluation after High-Risk TIA is Associated with Lower Stroke Risk
    Wu, Caren M.
    Manns, Braden J.
    Hill, Michael D.
    Ghali, William A.
    Donaldson, Cam
    Buchan, Alastair M.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2009, 36 (04) : 450 - 455
12345